Stonegate Initiates Coverage on SES AI Corp. (NYSE: SES)

Key Takeaways

  • SES is shifting from EV R&D toward commercialization, with ESS anchoring FY26 revenue and drone cells/materials adding clearer 2H26 and 2027 growth paths.
  • 1Q26 revenue beat was helped by timing, but stronger gross margin, improved mix, and reaffirmed $30M–$35M guidance support execution credibility.
  • Drone cells are the key upside variable, with NDAA-compliant samples shipping, defense interest building, and qualification potentially converting into fuller 2027 deliveries.

DALLAS, TX -- June 2, 2026 -- SES AI Corp. (NYSE: SES): Stonegate Capital Partners Initiates Coverage on SES AI Corp. (NYSE: SES). SES’ 1Q26 update further shifts the story from EV battery development toward a commercialization model led by ESS, with drone cells, materials, and Molecular Universe adding clearer 2H26/2027 revenue paths. Revenue beat expectations, though Q1 benefited from ~$1.5M of 4Q25 revenue shifting into the period, so the better read is not run-rate extrapolation but improved mix, reaffirmed FY26 guidance, and better visibility into drone qualification, cost reductions, and AI-enabled product differentiation.

Quarterly Results: Revenue was $6.7M, up 47% q/q and 16% y/y, above consensus of $3.65M, driven primarily by UZ Energy ESS sales with early drone sample and Molecular Universe subscription contributions. GAAP gross margin improved to 18.1% from 11.3% in 4Q25, while non-GAAP gross margin improved to 18.3% from 11.7%, reflecting better UZ margins and higher-margin mix. GAAP OpEx was $19.1M, non-GAAP OpEx was $14.3M, non-GAAP net loss was $11.1M, or $(0.03)/share, and adjusted EBITDA loss improved to $12.8M from $13.8M in 4Q25.

ESS / Edge Box: ESS remains the primary FY26 revenue driver. The ~$20M, three-year ATG EPower agreement gives UZ Energy a North American distribution channel across residential, commercial, and industrial customers. The more differentiated element is Edge Box, which combines ESS hardware with Molecular Universe Predict to improve battery state-of-charge/state-of health accuracy, reduce oversizing, support on-premise data security, and improve virtual power plant bidding decisions.

Drone Cells / Materials / Molecular Universe: Drone cells are the most important 2H26 swing factor. SES completed the Chungju line conversion, began shipping NDAA-compliant samples, and management indicated interest is predominantly defense-related. Qualification typically takes one to two quarters, with much of the product/performance testing already complete and the current focus shifting to supply-chain audits. Management expects Q2 drone revenue, a Q3/Q4 pickup, and 2027 as the first fuller-year delivery period. Materials remain earlier-stage, but approximately half a dozen customers have advanced through second-phase testing, while Molecular Universe gained validation through a multiyear Search-in-a-Box subscription with a major global battery manufacturer.

Guidance: SES reaffirmed FY26 revenue guidance of $30M–$35M, with 1H26 driven primarily by UZ Energy ESS revenue and drone/materials contributions expected to build in 2H26. Management still expects ~15% consolidated gross margin and a ~15% reduction in full-year OpEx from 2025 levels, with cost actions becoming more visible in Q3/Q4. SES ended 1Q26 with ~$178M of liquidity after ~$20M of operating cash use, supporting the Company’s capex-light growth plan and commercialization priorities. CFO Ray Liu was appointed effective April 27, 2026.


About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

SOURCE: Stonegate, Inc.

Key Takeaways

  • SES is shifting from EV R&D toward commercialization, with ESS anchoring FY26 revenue and drone cells/materials adding clearer 2H26 and 2027 growth paths.
  • 1Q26 revenue beat was helped by timing, but stronger gross margin, improved mix, and reaffirmed $30M–$35M guidance support execution credibility.
  • Drone cells are the key upside variable, with NDAA-compliant samples shipping, defense interest building, and qualification potentially converting into fuller 2027 deliveries.

Media Gallery

Related Bios

Dave Storms
Director of Research Stonegate Capital Markets
Dave is the Director of Research for Stonegate Capital Markets and provides contract research and valuation services for Stonegate Capital Partners. Dave joined the firm in 2022 and covers multiple sectors. Prior to this, he was an equity research analyst at Goldman Sachs. He was formerly a Senior investment analyst at Beneficial Financial Group, an analyst at Valuation Research Corporation, and an investment analyst with The Board of Pensions (PCUSA) focused on public equities
View Full Bio>>

Contacts

Stonegate Capital Partners
info@stonegateinc.com
(214) 987-4121
General